The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

PROCYCLIDINE AND BENZTROPINE METHANESULFONATE COMPARED IN DRUG INDUCED EXTRAPYRAMIDAL REACTIONS

Published Online:https://doi.org/10.1176/ajp.119.5.462

Seventy patients on acute intensive treatment with chlorpromazine, trifluoperazine, and fluphenazine were placed at random in two groups. Group A treated with benztropine methanesulfonate had 40 extrapyramidal symptoms of which 35 improved. Blurred vision or dry mouth developed in 17 instances. Group B treated with procyclidine had 40 extrapyramidal symptoms of which 39 improved with the development of only one side effect—blurred vision—in two patients. On the basis of this study it appears that procyclidine was the most effective drug in alleviating extrapyramidal symptoms. The number of side effects developing with procyclidine were at a minimum.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.